These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 816199)
21. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists. Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883 [No Abstract] [Full Text] [Related]
22. Incompatibilities in large volume parenterals. Bergman HD Drug Intell Clin Pharm; 1977 Jun; 11(6):345-60. PubMed ID: 10297006 [No Abstract] [Full Text] [Related]
23. Role of packaging in ethylene oxide sterilization. Panella JA Bull Parenter Drug Assoc; 1974; 28(4):188-96. PubMed ID: 4212326 [No Abstract] [Full Text] [Related]
24. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association. J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417 [No Abstract] [Full Text] [Related]
25. Work analysis of an admixture service. Sebastian G; Thielke TS Am J Hosp Pharm; 1983 Dec; 40(12):2149-53. PubMed ID: 6419588 [TBL] [Abstract][Full Text] [Related]
27. The expanding role of pharmacy. Interview by Nancy Agresta. Durgin J Hosp Formul; 1980 Apr; 15(4):287-90, 293. PubMed ID: 10245911 [No Abstract] [Full Text] [Related]
28. [Danger from the bottle?]. MMW Munch Med Wochenschr; 1979 Apr; 121(14):468-70. PubMed ID: 107430 [No Abstract] [Full Text] [Related]
29. Premixed intravenous admixtures: a positive development for hospital pharmacy. Lee HE Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393 [TBL] [Abstract][Full Text] [Related]
30. Continuous versus intermittent intravenous antibiotics. Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663 [No Abstract] [Full Text] [Related]
31. A comparison of premixed and non-premixed potassium chloride large-volume parenterals. Turco SJ Hosp Pharm; 1979 Dec; 14(12):720-2. PubMed ID: 10309085 [No Abstract] [Full Text] [Related]
32. Cost and time required to add potassium chloride to large-volume parenterals. Turco SJ Hosp Pharm; 1979 Dec; 14(12):718-9. PubMed ID: 10309084 [No Abstract] [Full Text] [Related]
34. Centralized intravenous additive services (CIVAS): the state of the art in 2010. Hecq JD Ann Pharm Fr; 2011 Jan; 69(1):30-7. PubMed ID: 21296215 [TBL] [Abstract][Full Text] [Related]
36. [Study of insoluble contaminants in large-volume parental infusion fluids, II. Evaluation of the degree of contamination with insoluble particles of parenteral infusion fluids produced by the pharmaceutical industry and hospital pharmacies]. Pawlaczyk J; Nowacka D; WawrzyĆczak D Acta Pol Pharm; 1982; 39(1-3):151-7. PubMed ID: 7180545 [No Abstract] [Full Text] [Related]
37. Evaluation of a disposable rubber closure or bulk irrigating solutions. Newton DW; Rogers AG; Croswell RW; Hendrix L Am J Hosp Pharm; 1972 Aug; 29(8):678-83. PubMed ID: 5052414 [No Abstract] [Full Text] [Related]
38. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies. Kastango ES JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322 [TBL] [Abstract][Full Text] [Related]
39. A new batch method of preparing intravenous piggyback solutions in polyvinylchloride containers. Levy R; Kleinberg M; Lee P Hosp Pharm; 1980 Oct; 15(10):504-6. PubMed ID: 10309298 [TBL] [Abstract][Full Text] [Related]
40. Predicting pharmaceutical incompatibilities of parenteral medications. Carlin HS; Perkins AJ Am J Hosp Pharm; 1968 Jun; 25(6):270-9. PubMed ID: 5656772 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]